Coralie Franck

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie

Clémence Basse, Claire Morel, Marie Alt et al. · ESMO Open · 2018 · 55 citations · Full text

Medicine, Oncology, Pathology +17

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft

Thibault Passeri, Ahmed Dahmani, Julien Masliah‐Planchon et al. · Cancers · 2022 · 21 citations · Full text

Medicine, Molecular Biology, Oncology +17

Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial

Célia Dupain, Julien Masliah‐Planchon, Céline Gu et al. · Molecular Oncology · 2020 · 19 citations · Full text

Medicine, Oncology, Pathology +17

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine

Célia Dupain, Tom Gutman, Elodie Girard et al. · BMC Biology · 2024 · 17 citations · Full text

Medicine, Bioinformatics, Oncology +17